Email this article 
Is Robenacoxib Superior to Meloxicam in Improving Patient Comfort in Dogs Diagnosed With a Degenerative Joint Process?
Published: 26/01/2016 in: Knowledge Summaries
Views
1280
HTML:
956
PDF:
485
Abstract
Clinical bottom line
At normal clinical doses, there is no evidence that robenacoxib would provide superior patient comfort compared to meloxicam.
Click to see References
Click to hide References
References
- Schmid, V.B. et al. (2009) Analgesic and anti-inflammatory actions of robenacoxib in acute joint inflammation in dog. Journal of Veterinary Pharmacology and Therapeutics, 33 (2), pp. 118-131. http://dx.doi.org/10.1111/j.1365-2885.2009.01117.x
Refbacks
- There are currently no refbacks.
Copyright (c) 2016 Adam Swallow
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.